您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (10): 45-48,60.doi: 10.6040/j.issn.1671-7554.0.2014.342

• 临床医学 • 上一篇    下一篇

进展性脑梗死患者血清Hs-CRP、SAA水平变化及意义

李宁1, 邓红琼1, 王翠兰2   

  1. 1. 济南市第三人民医院神经内科, 山东 济南 250101;
    2. 山东大学齐鲁医院神经内科, 山东 济南 250012
  • 收稿日期:2014-05-27 修回日期:2014-09-25 出版日期:2014-10-10 发布日期:2014-10-10
  • 通讯作者: 李宁。E-mail:lyn-kallen@163.com E-mail:lyn-kallen@163.com

Changes and significance of serum Hs-CRP and SAA in patients with progressive cerebral infarction

LI Ning1, DENG Hongqiong1, WANG Cuilan2   

  1. 1. Department of Neurology, Jinan Third People's Hospital, Jinan 250101, Shandong, China;
    2. Department of Neurology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-05-27 Revised:2014-09-25 Online:2014-10-10 Published:2014-10-10

摘要: 目的 探讨进展性脑梗死(PCI)患者血清超敏C反应蛋白(Hs-CRP)、血清淀粉样蛋白A(SAA)水平变化及临床意义。方法 选取34例PCI患者为PCI组,33例非进展性脑梗死(NPCI)患者为NPCI组,34例针对血管危险因素查体者为对照组。通过胶乳增强免疫比浊法检测血清Hs-CRP水平,酶联免疫吸附法(ELISA)检测SAA水平,并对患者采用斯堪的纳维亚卒中量表(SSS)进行评分。结果 相较于NPCI组、对照组,PCI组患者在入院1、3、7、14 d血清Hs-CRP、SAA水平明显升高(P均<0.01),且上述蛋白水平呈正相关(P<0.01)。此外,PCI患者第1天血清Hs-CRP、SAA水平与入院第3、21天时SSS评分均呈明显负相关(P均<0.05)。结论 PCI患者血清Hs-CRP、SAA水平明显升高,其早期水平与病情程度密切相关,提示血清Hs-CRP和SAA水平在PCI的临床进程中均起重要作用,这为PCI诊断及治疗提供了新思路。

关键词: 进展性脑梗死, 非进展性脑梗死, 血清淀粉样蛋白A, 超敏C-反应蛋白

Abstract: Objective To investigate changes and significance of serum high-sensitivity C-reactive protein (Hs-CRP) and serum amyloid A protein (SAA) in patients with progressive cerebral infarction (PCI). Methods A total of 107 participants were divided into 3 groups: PCI group (n=34), non-progressive cerebral infarction (NPCI) group (n=33) and control group (people with vascular risk factors who received clinical examinations, n=34). Hs-CRP levels were measured with immune nephelometry, and SAA levels were evaluated with enzyme-linked immunosorbent assay (ELISA). Patients were rated with the Scandinavian Stroke Scale (SSS) score. Results Compared with the NPCI group and controls, the Hs-CRP and SAA levels in the PCI group significantly increased on day 1, 3, 7, and 14 (all P<0.01). In the PCI group, Hs-CRP and SAA levels were positively correlated (P<0.01), and Hs-CRP and SAA levels one day 1 were negative correlated with the SSS on day 3 and 21 (all P<0.05). Conclusion Levels of Hs-CRP and SAA are significantly enhanced in PCI patients, which are closely related with the severity of disease, suggesting that Serum Hs-CRP and SAA play an important role in the progression of PCI.

Key words: Non-progressive cerebral infarction, Serum amyloid A protein, Progressive cerebral infarction, High-sensitivity C-reactive protein

中图分类号: 

  • R741
[1] Ong C T, Wu C S. Neurological deterioration in patients with first ever ischemic stroke[J]. Acta Neurol Taiwan, 2007, 16(3): 143-149.
[2] Rajeshwar K, Kaul S, Al-Hazzani A, et al. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome[J]. Inflammation, 2012, 35(3): 978-984.
[3] Lukasik M, Dworacki G, Kufel-Grabowska J, et al. Up regulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischemic stroke[J]. Thromb Haemost, 2012, 107(2): 346-355.
[4] Mao D J, Guo R Y, Tang Y C, et al. Expression of sCD40L in peripheral blood and NF-κBp65 in PBMC of patients with acute progressive cerebral infarction[J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011, 27(2): 177-179.
[5] O'Brien K D, Chait A. Serum amyloid A: the "other" inflammatory protein[J]. Curr Atheroscler Rep, 2006, 8(1): 62-68.
[6] Hua S, Song C, Geczy C L, et al. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis.A role for acute-phase serum amyloid and high-density[J]. Redox Rep, 2009, 14(5): 187-196.
[7] 魏衡, 杜继臣, 张绿明, 等. 血清淀粉样蛋白A与缺血性脑卒中及亚型的相关性研究[J]. 中国神经免疫学和神经病学杂志, 2010, 3(19): 183-186. WEI Heng, DU Jichen, ZHANG Lüming, et al. Association between ischemic stroke and serum amyloid A protein[J]. Chin J Neuroimmunol &Neurol, 2012, 3(19): 183-186.
[8] Liuzzo G, Biasucci L M, Gallimore J R, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina[J]. N Engl J Med, 1994, 331(7): 417-424.
[9] Brea D, Sobrino T, Blanco M, et al. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation[J]. Atherosclerosis, 2009, 205(2): 561-567.
[10] 中华神经科学会中华神经外科学会. 各类脑血管疾病诊断要点[J]. 中华神经科杂志, 1996, 29(6): 379-380.
[11] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志, 2010, 2(43): 146-153.
[12] Birschel P, Ellul J, Barer D, et al. Progressing stroke: towards an internationally agreed definition[J]. Cerebrovasc Dis, 2004, 17(2-3): 242-252.
[13] 张春华, 王炳莲, 田国栋. 高敏C-反应蛋白与进展性脑梗死相关性的临床观察[J]. 中国现代神经疾病杂志, 2010, 5(10): 583-584.
[14] 木崇仙. 超敏C反应蛋白、纤维蛋白原与进展性卒中的相关性[J].中国现代药物应用, 2012, 7(6):21-23.
[15] Kim S K, Song P, Hong J M, et al. Prediction of progressive motor deficits in patients with deep subcortical infarction[J]. Cerebrovasc Dis, 2008, 25(4): 297-303.
[16] Ridker P M, Danielson E, Fonseca F A, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial[J]. Lancet, 2009, 373(9670): 1175-1182.
[17] Wang L, Colón W. The interaction between apolipoprotein serum amyloid A and high-density lipoprotein[J]. Biochem Biophys Res Commun, 2004, 317(1): 157-161.
[18] 战晶晶, 金丽英, 王海萍, 等. 缺血性脑血管病病人SAA水平检测与意义[J]. 青岛大学医学院学报, 2011, 47(2): 110-112.
ZHAN Jingjing, JIN Liying, WANG Haiping, et al. Determination and significance of saa in patients with ischemic cerebrovascular disease[J]. Acta Academiae Medicinae Qingdao Universitatis, 2011, 47(2): 110-112.
[19] Rallidis L S, Vikelis M, Panagiotakos D B, et al. Inflammatory markers and in-hospital mortality in acute ischemic stroke.Inflammatory markers and in-hospital mortality in acute ischemic stroke[J]. Atherosclerosis, 2006, 189(1): 193-197.
[20] 李骞. 不同剂量瑞舒伐他汀对动脉粥样硬化大鼠SAA、hs-CRP水平的影响[J]. 当代医学, 2012, 5(18): 131-132.
[21] 李强, 凌芳, 聂德云, 等. 阿托伐他汀对急性脑梗死患者血脂和血清妊娠相关蛋白A等炎性因子的影响[J]. 中国脑血管病杂志, 2011, 8(6): 308-311.
LI Qiang, LING Fang, NIE Deyun, et al. Effects of intensive lipid-lowering therapy on the changes of serum pregnancy-associated plasma protein levels in patients with acute cerebral infarction[J]. Chin J Cerebrovasc Dis, 2011, 8(6): 308-311.
[1] 宓特,屈传强,王翔,尹苓,薛媛,杜怡峰. 血清淀粉样蛋白A与脑梗死急性期认知功能的相关性[J]. 山东大学学报(医学版), 2016, 54(10): 40-45.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!